Amplification of the mdm-2 gene and p53 abnormalities in uterine sarcomas

International Journal of Cancer

Volumn 73, Issue 1, 1997, Pages 33-37

  Seki, Akihiko ^a   Kodama, Junichi ^a   Miyagi, Yasunari ^a   Kamimura, Shigehito ^a   Yoshinouchi, Mitsuo ^a   Kudo, Takafumi ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CARCINOGENESIS; CELL GROWTH; CONTROLLED STUDY; GENE AMPLIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UTERUS SARCOMA;

ADULT; AGED; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MDM2; SARCOMA; TUMOR SUPPRESSOR PROTEIN P53; UTERINE NEOPLASMS;

EID: 0030873968     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970926)73:1<33::AID-IJC6>3.0.CO;2-2     Document Type: Article

References (24)

1. CAHILLY-SNYDER. L., YANG-FENG. T., FRANCKE, U. and GEORGE, D.L., Molecular analysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line. Somat. Cell. mol. Genet., 13, 235-244 (1987).
2. EL-DEIRY. W.S., TOKINO. T., VELCULESCU. V.E., LEW. D.B., PARSONS. R., TRENT, J.M., LIN. D., MERCER. W.E., KINZLER. K.W. and VOGELSTEIN. B., WAF1. a potential mediator of p53 tumor suppression. Cell, 75, 817-825 (1993).
3. FAKHARZADEH. S.S., TRUSKO. S.P. and GEORGE. D.L., Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line. EMBO J. 10, 1565-1569 (1991).
4. FORUS. A., FLORENES. V.A., MAELANDSMO, G.M., MELTZER, P.S., FODSTAD, O. and MVKLEBOST. O., Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: some amplica do not include MDM2. Cell Gmwth Differ., 4, 1065-1070 (1993).
5. FRYE. R.A., BENZ, C.C. and LIU, E., Detection of amplified oncogenes by differential polymerase chain reaction. Oncogene, 4, 1153-1157 (1989).
6. KODAMA, J., HAYASE. R., OKUDA. H., YOSHINOUCHI, M. and KUDO, T., Reverse correlation between P-glycoprotein expression and proliferative activity in endometrial adenocarcinoma. Europ. J. Obstet. Gynecol. reprod. Biol., 59, 45-51 (1994).
7. LAWN. R.M., EFSTRATIADIS. A., O'CONNELL, C. and MAMATIS, T., The nucleotide sequence of the human beta-globin gene. Cell, 21, 647-651 (1980).
8. LEVINE, A.J., PERRY. M.E., CHANG. A., SILVER. A., DITTMER. D., WU, M. and WELSH. D., The 1993 Walter Hubert lecture: The role of the p53 tumor-suppressor gene in tumorigenesis. Brit. J. Cancer, 69, 409-416 (1994).
9. LIVINGSTONE, L.R., WHITE, A., SPROUSE, J., LIVANOS. E., JACKS, T. and TLSTY, T.D., Altered cell-cycle arrest and gene-amplification potential accompany loss of wild-type p53. Cell, 70, 923-935 (1992).
10. MOMAND. J., ZAMBETTI. G.P., OLSON, D.C., GEORGE, D. and LEVINE, A.J., The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell, 69, 1237-1245 (1992).
11. MULDER, J.W., OFFERHAUS. G.J., VOGELSTEIN, B. and HAMILTON, S.R., An evaluation of six antibodies for immunohistochemistry of mutant p53-gene product in archival colorectal neoplasms. J. Pathol., 172, 5-12 (1994).
12. NAKANISHI, Y., KODAMA, J., YOSHINOUCHI, M., TOKUMO, K., KAMIMURA, S., OKUDA, H. and KUDU, T., The expression of vascular endothelial growth factor and transforming growth factor-β associates with angiogenesis in epithelial ovarian cancer. Int. J. gynecol. Pathol. (1997) (In press).
13. NEUBAUER, A., NEUBAUER. B., HE, M., EFFERT. P., IGLEHART, D., FRYE. R.A. and LIU, E., Analysis of gene amplification in archival tissue by differential polymerase chain reaction. Oncogene, 7, 1019-1025 (1992).
14. NILBERT, M., RYDHOLM, A., WILLEN, H., MITELMAN, F. and MANDAHL. N., MDM2-gene amplification correlates with ring chromosome in soft-tissue tumors, Genes Chromosomes Cancer, 9, 261-265 (1994).
15. OLINER. J.D., KINZLER. K.W., MELTZER. P.S., GEORGE, D.L. and VOGELSTEIN, B., Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature (Lond.), 358, 80-83 (1992).
16. PERRY, M.E. and LEVINE, A.J., Tumor-suppressor p53 and the cell cycle. Curr. Opin. Genet. Dev., 3, 50-54 (1993).
17. PERRY. M.E., PIETTE. J., ZAWADZKI, J.A., HARVEY. D. and LEVINE, A.J., The mdm-2 gene is induced in response to UV light in a p53-dependent manner. Proc. nat. Acad. Sci. (Wash.), 90, 11623-11627 (1993).
18. REIRENBERGER, G., LIU, L., ICHIMURA, K., SCHMIDT, E.E. and COLLINS, V.P., Amplification and over-expression of the MDM2 gene in a sub-set of human malianant gliomas without p53 mutation. Cancer Res., 53, 2736-2739 (1993).
19. REIFENBERGER. G., REIFENBERGFR. J., ICHIMURA, K., MELTZER, P.S. and COLLINS. V.P., Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS and MDM2. Cancer Res., 54, 4299-4303 (1994).
20. SEKI. A., NAKAMURA. K., KODAMA. J., KAMIMURA, S., MIYAGI, Y., YOSHINOUCHI, M. and KUDO, T., A close correlation between the c-erbB-2-gene amplification and local progression in endometrial adenocarcinoma. Europ. J. Gynaecol. Oncol. (1997) (In press).
21. VOJTESEK, B., BMGTEK. J., MIDGLEY. C.A. and LANE, D.P., An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53. J. immunol. Methods, 151, 237-244 (1992).
22. VOUSDEN, K., Interactions of human-papillomavirus-transforming proteins with the products of tumor-suppressor genes. FASEB J., 7, 872-879 (1993).
23. WU, X., BAYLE, J.H., OLSON, D. and LEVINE, A.J., The p53-mdm-2 autoregulatory feedback loop. Genes Dev., 7, 1126-1132 (1993).
24. YIN. Y. TAINSKY, M.A., BISCHOFF, F.Z., STRONG, L.C. and WAHL, G.M., Wild-type p53 restores cell-cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70, 937-948 (1992).